Detection of COVID-19 Using Breath Analysis - Validation Study.

NCT05224622 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 192

Last updated 2023-05-31

No results posted yet for this study

Summary

Detection of the 2019 novel Coronavirus (SARS-CoV-2) using breath analysis - Validation study.

Conditions

Interventions

DIAGNOSTIC_TEST

VOX

Breath exhalation into the mouthpiece of the VOX breath diagnostic device.

Sponsors & Collaborators

  • Scentech Medical Technologies Ltd

    lead INDUSTRY

Principal Investigators

  • Avi Peretz, PhD · Poriya Medical Center

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-01-18
Primary Completion
2022-05-28
Completion
2023-01-18

Countries

  • Israel

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05224622 on ClinicalTrials.gov